Cenforce
Cenforce Price range: $ 40,00 through $ 1 100,00
Back to products
Cenforce Soft
Cenforce Soft Price range: $ 44,00 through $ 324,00

Cenforce Professional

Price range: $ 80,00 through $ 202,00

Cenforce Professional is a potent sublingual medication designed to effectively treat erectile dysfunction in men. Formulated with high-quality Sildenafil Citrate, it works by increasing blood flow to the pelvic area to support firm and lasting erections. The sublingual tablet dissolves quickly under the tongue, allowing for faster absorption into the bloodstream compared to traditional oral pills. This advanced formula provides reliable results, helping users regain confidence and improve their overall sexual performance. Experience enhanced stamina and a more satisfying intimate life with this convenient and fast-acting solution.

Active substance: Sildenafil Citrate
SKU: Cenforce Professional Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Cenforce Professional operates by selectively inhibiting the phosphodiesterase type 5 (PDE5) enzyme, which is responsible for the degradation of cyclic guanosine monophosphate (cGMP) in vascular smooth muscle cells. This targeted enzymatic inhibition leads to enhanced accumulation of cGMP, facilitating vascular smooth muscle relaxation and promoting increased arterial blood inflow to specific tissues during physiological stimulation.

The active therapeutic component of this sublingual formulation is sildenafil citrate, a standard agent in male erectile dysfunction management. In the United States, formulations containing sildenafil are classified as prescription-only medications and must be dispensed strictly in accordance with applicable federal and state legal requirements.

Active Ingredient (INN): Sildenafil Citrate

Pharmacologic Class: Phosphodiesterase Type 5 (PDE5) Inhibitor

Dosage Form: Sublingual Tablet

Primary Purpose: Treatment of Erectile Dysfunction (ED)

Prescription Status: Rx Only (Prescription Required)

Route of Administration: Sublingual / Oral

Mechanism of Action

The pharmacological profile of sildenafil centers on the inhibition of cGMP-specific phosphodiesterase type 5. During sexual stimulation, local neuronal release of nitric oxide (NO) stimulates the enzyme guanylate cyclase, which increases intracellular levels of cyclic guanosine monophosphate (cGMP). Elevated cGMP leads to smooth muscle relaxation in the corpus cavernosum and penile arterioles. PDE5 is the primary enzyme responsible for cGMP degradation in these tissues. By selectively blocking PDE5, sildenafil preserves cGMP concentrations, thereby sustaining physiological erectile response. The drug does not exert a direct relaxant effect on isolated human corpus cavernosum in the absence of nitric oxide release, meaning physiological stimulation remains necessary to elicit therapeutic action.

Main Uses

The primary clinical indication for sildenafil citrate is the treatment of erectile dysfunction (ED) in adult males, characterized by the persistent inability to achieve or maintain an erection sufficient for satisfactory performance. Beyond ED, sildenafil is approved under distinct pharmaceutical trade names and specific dosing protocols for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability. However, utilizing Cenforce Professional for cardiovascular conditions such as PAH is considered an off-label use. Prescribers must evaluate off-label application carefully, as dosing regimens and administration methods for PAH differ significantly from those used for erectile dysfunction.

What Happens in the Body

Following sublingual or oral administration, sildenafil is rapidly absorbed into the systemic circulation. When ingested in a fasting state, peak plasma concentrations (Cmax) are typically achieved within 30 to 120 minutes (median approximately 60 minutes). The absolute oral bioavailability of sildenafil is approximately 40% due to extensive first-pass hepatic metabolism. The drug undergoes biotransformation predominantly via the cytochrome P450 hepatic isoenzyme CYP3A4 (major pathway) and to a lesser extent via CYP2C9 (minor pathway). The primary circulating metabolite, N-desmethyl sildenafil, exhibits PDE selectivity similar to the parent compound with approximately 50% of its potency. Sildenafil and its active metabolite have terminal elimination half-lives of approximately 3 to 5 hours. Excretion occurs primarily as inactive metabolites in the feces (approximately 80% of administered dose) and secondarily in the urine (approximately 13%).

Administration and Dosage Guidelines

Dosing Schedule

The standard recommendation for sildenafil administration requires placing the sublingual tablet under the tongue to allow complete dissolution prior to anticipated activity. The typical starting dose is determined individually by a licensed prescriber based on patient response, age, renal function, and concurrent medications. Sildenafil is taken as needed, ideally 30 to 60 minutes prior to sexual activity. The maximum recommended administration frequency is once per 24-hour period. Doses should not be escalated without direct instruction from a healthcare provider.

If You Skip a Dose

Because Cenforce Professional is administered strictly on an as-needed basis prior to sexual activity rather than on a continuous daily schedule, a missed dose protocol is generally not applicable. Patients should never take a double dose or increase the frequency of administration beyond once daily to make up for a missed or delayed dose.

Drug Interaction Overview

Compatibility with Other Medicines

Co-administration of sildenafil with organic nitrates (such as nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate) in any form is strictly contraindicated due to the risk of severe, potentially life-threatening hypotension. Similarly, administration alongside guanylate cyclase stimulators like riociguat is contraindicated due to additive hypotensive effects. Concomitant use of alpha-blockers (e.g., doxazosin, tamsulosin) prescribed for hypertension or benign prostatic hyperplasia may cause symptomatic orthostatic hypotension; therapy should only be initiated if the patient is stable on their alpha-blocker regimen. Strong CYP3A4 inhibitors, such as ketoconazole, itraconazole, ritonavir, and erythromycin, significantly increase sildenafil exposure, requiring dose reduction and careful clinical monitoring.

What to Avoid While Taking It

High-fat meals ingested concurrently with sildenafil can delay the rate of absorption, extending the time to reach peak plasma concentration by approximately one hour and reducing overall peak concentration. Moderate to heavy alcohol consumption should be avoided, as ethanol possesses intrinsic vasodilatory properties that can compound the blood pressure-lowering effects of PDE5 inhibitors, increasing the risk of dizziness, tachycardia, and orthostatic lightheadedness.

Safety Profile and Warnings

Adverse Reactions

In clinical trials and post-marketing surveillance, the most frequently reported adverse reactions associated with sildenafil include headache, flushing, dyspepsia, nasal congestion, back pain, myalgia, and mild, transient visual disturbances. Visual disturbances are typically characterized by altered color perception (a blue/green tinge to vision), increased sensitivity to light, or blurred vision, which occur due to secondary inhibition of PDE6 in the retina. Less common side effects include dizziness, rash, epistaxis, and gastrointestinal discomfort.

Red Flags

Immediate emergency medical care is required if any of the following severe adverse events occur during treatment:

  • Priapism, defined as a prolonged and painful erection lasting longer than 4 hours, which can lead to irreversible penile tissue damage if untreated.
  • Sudden, unilateral or bilateral loss of vision, which may be a sign of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION).
  • Sudden decrease or loss of hearing, occasionally accompanied by tinnitus or dizziness.
  • Chest pain, severe dizziness, or symptoms of myocardial infarction during or after sexual activity.
  • Severe hypersensitivity reactions, including facial swelling, swelling of the tongue or throat, hives, and respiratory distress.

Important Precautions

Cardiovascular evaluation is essential prior to initiating sildenafil, as sexual activity carries an inherent degree of cardiac risk for patients with pre-existing heart conditions. Sildenafil is not recommended for individuals with severe left ventricular outflow obstruction, resting hypotension (blood pressure < 90/50 mmHg), or unstable angina. Patients with severe hepatic impairment or severe renal impairment (creatinine clearance < 30 mL/min) exhibit reduced drug clearance and typically require adjusted starting doses. The safety of sildenafil has not been established in patients with bleeding disorders or active peptic ulceration.

Storage and Expiration

Cenforce Professional should be stored at controlled room temperature between 68°F and 77°F (20°C to 25°C), with permitted excursions between 59°F and 86°F (15°C to 30°C). The preparation must be kept in its original packaging to protect the sublingual tablets from excessive moisture and light. Store safely out of reach of children and pets. Do not use this medication after the expiration date clearly stamped on the packaging.

Common Questions

Q: Does taking sildenafil with food alter its therapeutic effect?

A: Yes. Consuming a meal high in dietary fat prior to taking sildenafil can slow down the rate of absorption, meaning the medication may take longer to demonstrate efficacy compared to administration in a fasting state.

Q: Is it permissible to drive after taking Cenforce Professional?

A: Patients should assess their individual physiological response to the medication before driving or operating heavy machinery. Because sildenafil can cause dizziness and transient visual disturbances such as blue-tinted vision or light sensitivity, caution is advised if these effects occur.

Q: What is the expected physiological duration of action for sildenafil?

A: The plasma elimination half-life of sildenafil is approximately 3 to 5 hours. While the drug remains active in the systemic circulation within this window, an erection will only occur during this period in the presence of physical sexual stimulation.

Q: Can sildenafil be taken simultaneously with antihypertensive medications?

A: Caution is required when combining sildenafil with blood pressure-lowering medications, particularly alpha-blockers. Because both agents lower systemic vascular resistance, combined use can cause additive blood pressure drops leading to dizziness or fainting. Prescriber consultation is mandatory before combined use.

Q: Are visual changes caused by PDE5 inhibitors permanent?

A: Mild visual changes, such as cyanopsia (a bluish tinge to vision) or heightened light awareness, are typically transient and resolve as circulating drug concentrations decline. However, sudden total loss of vision requires urgent medical evaluation as it may indicate a rare vascular condition known as NAION.

This text is for informational purposes only and does not constitute individual medical advice.

In accordance with FDA requirements and federal law, prescription medications must be taken strictly under the guidance of a qualified, licensed healthcare professional.

Additional information
Dosage

100 mg

Package

90 pills

,

120 pills

,

150 pills

,

300 pills

Ενεργός Ουσία